Cite
HARVARD Citation
Perdigoto, D. et al. (n.d.). P537 Adalimumab: Relevance of drug trough levels and antibodies assessment in the prognosis of Crohn's disease. Journal of Crohn's and colitis. pp. S377-S378. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Perdigoto, D. et al. (n.d.). P537 Adalimumab: Relevance of drug trough levels and antibodies assessment in the prognosis of Crohn's disease. Journal of Crohn's and colitis. pp. S377-S378. [Online].